aspirin has been researched along with Diathesis in 40 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite its well-known antithrombotic properties, the effect of aspirin on blood pressure (BP) and hypertension pathology is unclear." | 7.91 | Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat. ( Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A, 2019) |
| "The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been associated with reduced breast cancer risk, but it is not known if this association extends to women at familial or genetic risk." | 7.91 | Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. ( Andrulis, IL; Buys, SS; Chung, WK; Cigler, T; Daly, MB; Dite, GS; Friedlander, ML; Giles, GG; Glendon, G; Hopper, JL; John, EM; Kehm, RD; Knight, JA; Kornhauser, N; Liao, Y; MacInnis, RJ; McLachlan, SA; Milne, RL; Nesci, S; Phillips, KA; Southey, MC; Terry, MB; Vahdat, L; Weideman, PC; Zeinomar, N, 2019) |
| "It was effective in reducing preterm preeclampsia, but not term preeclampsia, and patient compliance and patient weight were important variables." | 6.72 | The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta. ( Strauss, JF; Walsh, SW, 2021) |
| "Despite its well-known antithrombotic properties, the effect of aspirin on blood pressure (BP) and hypertension pathology is unclear." | 3.91 | Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat. ( Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A, 2019) |
| "The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been associated with reduced breast cancer risk, but it is not known if this association extends to women at familial or genetic risk." | 3.91 | Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. ( Andrulis, IL; Buys, SS; Chung, WK; Cigler, T; Daly, MB; Dite, GS; Friedlander, ML; Giles, GG; Glendon, G; Hopper, JL; John, EM; Kehm, RD; Knight, JA; Kornhauser, N; Liao, Y; MacInnis, RJ; McLachlan, SA; Milne, RL; Nesci, S; Phillips, KA; Southey, MC; Terry, MB; Vahdat, L; Weideman, PC; Zeinomar, N, 2019) |
| "The study aimed to investigate the role of medical history (skin warts, Candida albicans, herpetic lesions, heartburn, regurgitation) and medication use (for heartburn; for regurgitation; aspirin) in the aetiology of upper aerodigestive tract (UADT) cancer." | 3.78 | Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. ( Agudo, A; Ahrens, W; Barzan, L; Benhamou, S; Bouchardy, C; Brennan, P; Canova, C; Castellsague, X; Conway, DI; Healy, CM; Kjaerheim, K; Lagiou, A; Lagiou, P; Macfarlane, GJ; Macfarlane, TV; Marron, M; McCartan, BE; McKinney, PA; Merletti, F; Plzak, J; Pohlabeln, H; Richiardi, L; Simonato, L; Slamova, A; Sloan, P; Talamini, R; Thakker, NS; Thomson, P; Znaor, A, 2012) |
| " In this study we aimed to analyze the epigenetic patterns, in terms of DNA methylation, of three well-characterized populations of house dust mite allergic subjects, aspirin-intolerant asthmatics and controls." | 3.77 | Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma. ( Dávila, I; Greally, JM; Isidoro-Garcia, M; Lorente, F; Padrón, J; Pascual, M; Suzuki, M; Turner, T, 2011) |
| "It was effective in reducing preterm preeclampsia, but not term preeclampsia, and patient compliance and patient weight were important variables." | 2.72 | The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta. ( Strauss, JF; Walsh, SW, 2021) |
| "Uncorrected bleeding diathesis might increase the risk and is considered to be an absolute contraindication for SWL." | 2.50 | Antiplatelet and anticoagulative medication during shockwave lithotripsy. ( Bründl, J; Burger, M; Chaussy, CG; Fritsche, HM; Gierth, M; Schnabel, MJ, 2014) |
| " In order to achieve the desired results and, as with all medications, PPIs should always be used appropriately taking care never to exceed correct dosage and duration." | 2.47 | Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections. ( Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A, 2011) |
| "However, some patients may develop acute liver failure and successful orthotopic liver transplantation may be undertaken in such patients." | 2.42 | Hepatocellular damage from non-steroidal anti-inflammatory drugs. ( Dargan, PI; Jones, AL; O'Connor, N, 2003) |
| "Dipyridamole use was related to a lower risk of lymphoid neoplasms, indicating a clinical potential of dipyridamole to be an adjunct anti-tumour agent against lymphoid neoplasms." | 1.72 | Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study. ( Huang, W; Ji, J; Sundquist, J; Sundquist, K, 2022) |
| "Treatment with aspirin inhibited spontaneous platelet aggregation but had little effect on the activated platelet profile." | 1.29 | Platelet activation and thrombosis: studies in a patient with essential thrombocythemia. ( Bihour, C; Nurden, AT; Nurden, P; Raymond, JM; Smith, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (20.00) | 18.7374 |
| 1990's | 9 (22.50) | 18.2507 |
| 2000's | 5 (12.50) | 29.6817 |
| 2010's | 11 (27.50) | 24.3611 |
| 2020's | 7 (17.50) | 2.80 |
| Authors | Studies |
|---|---|
| Mullol, J | 1 |
| Boyce, J | 1 |
| Dahlén, SE | 1 |
| Dahlén, B | 1 |
| Picado, C | 1 |
| Bobolea, I | 1 |
| Huang, W | 1 |
| Sundquist, K | 1 |
| Sundquist, J | 1 |
| Ji, J | 1 |
| Zhu, D | 1 |
| Zou, H | 1 |
| Liu, J | 1 |
| Wang, J | 1 |
| Ma, C | 1 |
| Yin, J | 1 |
| Peng, X | 1 |
| Li, D | 1 |
| Yang, Y | 1 |
| Ren, Y | 1 |
| Zhang, Z | 1 |
| Zhou, P | 1 |
| Wang, X | 1 |
| Cao, Y | 1 |
| Xu, X | 1 |
| Arshi, S | 1 |
| Eslami, N | 1 |
| Nabavi, M | 1 |
| Bemanian, MH | 1 |
| Fallahpour, M | 1 |
| Shokri, S | 1 |
| Ahmadian, J | 1 |
| Molatefi, R | 1 |
| Darabi, K | 1 |
| Sedighi, GR | 1 |
| Moinfar, Z | 1 |
| Darougar, S | 1 |
| Walsh, SW | 1 |
| Strauss, JF | 1 |
| Kohanski, MA | 1 |
| Cohen, NA | 1 |
| Barrett, NA | 1 |
| Piedra, K | 1 |
| Peterson, T | 1 |
| Tan, C | 1 |
| Orozco, J | 1 |
| Hultcrantz, M | 1 |
| Hassoun, H | 1 |
| Mailankody, S | 1 |
| Lesokhin, A | 1 |
| Shah, U | 1 |
| Lu, S | 1 |
| Patel, D | 1 |
| Derkach, A | 1 |
| Wilkins, CR | 1 |
| Korde, N | 1 |
| Lajoie, J | 1 |
| Mwangi, L | 1 |
| Fowke, KR | 1 |
| Santucci-Pereira, J | 1 |
| Pogash, TJ | 1 |
| Patel, A | 1 |
| Hundal, N | 1 |
| Barton, M | 1 |
| Camoirano, A | 1 |
| Micale, RT | 1 |
| La Maestra, S | 1 |
| Balansky, R | 1 |
| De Flora, S | 1 |
| Russo, J | 1 |
| Khan, SI | 1 |
| Shihata, WA | 1 |
| Andrews, KL | 1 |
| Lee, MKS | 1 |
| Moore, XL | 1 |
| Jefferis, AM | 1 |
| Vinh, A | 1 |
| Gaspari, T | 1 |
| Dragoljevic, D | 1 |
| Jennings, GL | 1 |
| Murphy, AJ | 1 |
| Chin-Dusting, JPF | 1 |
| Mastalerz, L | 1 |
| Tyrak, KE | 1 |
| Ignacak, M | 1 |
| Konduracka, E | 1 |
| Mejza, F | 1 |
| Ćmiel, A | 1 |
| Buczek, M | 1 |
| Kot, A | 1 |
| Oleś, K | 1 |
| Sanak, M | 1 |
| Kehm, RD | 1 |
| Hopper, JL | 1 |
| John, EM | 1 |
| Phillips, KA | 1 |
| MacInnis, RJ | 1 |
| Dite, GS | 1 |
| Milne, RL | 1 |
| Liao, Y | 1 |
| Zeinomar, N | 1 |
| Knight, JA | 1 |
| Southey, MC | 1 |
| Vahdat, L | 1 |
| Kornhauser, N | 1 |
| Cigler, T | 1 |
| Chung, WK | 1 |
| Giles, GG | 1 |
| McLachlan, SA | 1 |
| Friedlander, ML | 1 |
| Weideman, PC | 1 |
| Glendon, G | 1 |
| Nesci, S | 1 |
| Andrulis, IL | 1 |
| Buys, SS | 1 |
| Daly, MB | 1 |
| Terry, MB | 1 |
| Schnabel, MJ | 1 |
| Gierth, M | 1 |
| Bründl, J | 1 |
| Chaussy, CG | 1 |
| Burger, M | 1 |
| Fritsche, HM | 1 |
| Arcanjo, AF | 1 |
| LaRocque-de-Freitas, IF | 1 |
| Rocha, JD | 1 |
| Zamith, D | 1 |
| Costa-da-Silva, AC | 1 |
| Nunes, MP | 1 |
| Mesquita-Santos, FP | 1 |
| Morrot, A | 1 |
| Filardy, AA | 1 |
| Mariano, M | 1 |
| Bandeira-Melo, C | 1 |
| DosReis, GA | 1 |
| Decote-Ricardo, D | 1 |
| Freire-de-Lima, CG | 1 |
| Smilowitz, NR | 1 |
| Berger, JS | 1 |
| Laria, A | 1 |
| Zoli, A | 1 |
| Gremese, E | 1 |
| Ferraccioli, GF | 1 |
| Macfarlane, TV | 1 |
| Macfarlane, GJ | 1 |
| Thakker, NS | 1 |
| Benhamou, S | 1 |
| Bouchardy, C | 1 |
| Ahrens, W | 1 |
| Pohlabeln, H | 1 |
| Lagiou, P | 1 |
| Lagiou, A | 1 |
| Castellsague, X | 1 |
| Agudo, A | 1 |
| Slamova, A | 1 |
| Plzak, J | 1 |
| Merletti, F | 1 |
| Richiardi, L | 1 |
| Talamini, R | 1 |
| Barzan, L | 1 |
| Kjaerheim, K | 1 |
| Canova, C | 1 |
| Simonato, L | 1 |
| Conway, DI | 1 |
| McKinney, PA | 1 |
| Thomson, P | 1 |
| Sloan, P | 1 |
| Znaor, A | 1 |
| Healy, CM | 1 |
| McCartan, BE | 1 |
| Marron, M | 1 |
| Brennan, P | 1 |
| Pascual, M | 1 |
| Suzuki, M | 1 |
| Isidoro-Garcia, M | 1 |
| Padrón, J | 1 |
| Turner, T | 1 |
| Lorente, F | 1 |
| Dávila, I | 1 |
| Greally, JM | 1 |
| Souza, MH | 1 |
| de Lima, OM | 1 |
| Zamuner, SR | 1 |
| Fiorucci, S | 1 |
| Wallace, JL | 1 |
| Demiroglu, H | 1 |
| CAMERON, J | 1 |
| MENGUY, R | 1 |
| O'Connor, N | 1 |
| Dargan, PI | 1 |
| Jones, AL | 1 |
| Liao, JK | 1 |
| Van Dyke, TE | 1 |
| Jones, DH | 1 |
| May, AG | 1 |
| Condemi, JJ | 1 |
| Moor, E | 1 |
| Hamsten, A | 1 |
| Blombäck, M | 1 |
| Herzfeld, I | 1 |
| Wiman, B | 1 |
| Rydén, L | 1 |
| Tanira, MO | 1 |
| el-Sabban, FF | 1 |
| Fahim, MA | 1 |
| Wasfi, IA | 1 |
| Nurden, P | 1 |
| Bihour, C | 1 |
| Smith, M | 1 |
| Raymond, JM | 1 |
| Nurden, AT | 1 |
| Fedoseev, GB | 1 |
| Petrishchev, NN | 1 |
| Evsiukova, EV | 1 |
| Saniabadi, AR | 1 |
| Takeich, S | 1 |
| Yukawa, N | 1 |
| Nakajima, Y | 1 |
| Umemura, K | 1 |
| Nakashima, M | 1 |
| Liu, GS | 1 |
| Stanley, AW | 1 |
| Downey, J | 1 |
| Joseph, R | 1 |
| Han, E | 1 |
| Tsering, C | 1 |
| Grunfeld, S | 1 |
| Welch, KM | 1 |
| Perichon, B | 1 |
| Krishnamoorthy, R | 1 |
| Vial, JH | 1 |
| McLeod, LJ | 1 |
| Roberts, MS | 1 |
| Lawson, D | 1 |
| Mehta, J | 1 |
| Mehta, P | 1 |
| Lipman, BC | 1 |
| Imperi, GA | 1 |
| White, RF | 1 |
| Dumas, E | 1 |
| Shaw, P | 1 |
| Antoniw, JF | 1 |
| Olson, CE | 1 |
| Soll, AH | 1 |
| Guth, PH | 1 |
| Yokoyama, M | 1 |
| Tomoi, M | 1 |
| Taguchi, T | 1 |
| Nakano, T | 1 |
| Asai, H | 1 |
| Ono, T | 1 |
| Kitamura, Y | 1 |
| Pfeiffer, CJ | 1 |
| Weibel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Limiting HIV Target Cells by Inducing Immune Quiescence in the Female Genital Tract[NCT02079077] | 91 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
| The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery in Patients at a High Risk of Cardiac Events[NCT05733208] | 766 participants (Anticipated) | Interventional | 2023-05-06 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
We will measure changes in the number of CD4+T cells expressing CCR5 at the female genital tract before and at the end of the study. (NCT02079077)
Timeframe: baseline and 8 weeks
| Intervention | percentage of cells (Median) |
|---|---|
| Acetylsalicylic Acid (ASA) | 17.60 |
| Hydroxychloroquine (HCQ) | 22.10 |
We will analyse reduce of immune activation by measuring change in T cell activation (CD69) between baseline and every month during drug administration phase (8 weeks). (NCT02079077)
Timeframe: Baseline and 8 weeks
| Intervention | percentage of cells (Mean) | |
|---|---|---|
| Average of CD4+CD69+ at baseline | Average of CD4+CD69+ T cells cells after treatment | |
| Acetylsalicylic Acid (ASA) | 4.04 | 4.9 |
| Hydroxychloroquine (HCQ) | 5.55 | 4.99 |
9 reviews available for aspirin and Diathesis
| Article | Year |
|---|---|
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.
Topics: Animals; Aspirin; Biomarkers; Disease Management; Disease Susceptibility; Female; Gene Expression; H | 2021 |
Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention.
Topics: Aspirin; Disease Susceptibility; Female; Genitalia, Female; HIV Infections; HIV Seronegativity; HIV- | 2017 |
Antiplatelet and anticoagulative medication during shockwave lithotripsy.
Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Contraindications; Disease Susceptibility; Hemorrh | 2014 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspi | 2016 |
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioide | 2011 |
Hepatocellular damage from non-steroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemical and Drug Induced Liver Injury; D | 2003 |
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyr | 2007 |
Control of inflammation and periodontitis.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Aspirin; Biofilms; Bone Regeneration; Disease | 2007 |
[Aspirin-induced asthma (its clinical picture, pathogenesis and treatment)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation Tests; Combined Moda | 1997 |
1 trial available for aspirin and Diathesis
| Article | Year |
|---|---|
Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
Topics: Acute-Phase Proteins; Aged; Aspirin; Blood Coagulation; Blood Coagulation Factors; Coronary Artery B | 1994 |
30 other studies available for aspirin and Diathesis
| Article | Year |
|---|---|
Eicosanoid dysregulation and type 2 inflammation in AERD.
Topics: Aspirin; Biomarkers; Disease Susceptibility; Eicosanoids; Humans; Inflammation; Respiratory Tract Di | 2021 |
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Chemoprevention; Comorbidity; Dipyridamole; Disease Susceptibility | 2022 |
Inhibition of HMGB1 Ameliorates the Maternal-Fetal Interface Destruction in Unexplained Recurrent Spontaneous Abortion by Suppressing Pyroptosis Activation.
Topics: Abortion, Habitual; Adult; Animals; Aspirin; Biomarkers; Decidua; Disease Management; Disease Models | 2021 |
Aspirin Sensitivity in Patients with Moderate to Severe Asthma.
Topics: Adolescent; Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; As | 2020 |
Epithelial dysregulation in chronic rhinosinusitis with nasal polyposis (CRSwNP) and aspirin-exacerbated respiratory disease (AERD).
Topics: Aspirin; Biomarkers; Chronic Disease; Disease Progression; Disease Susceptibility; Humans; Nasal Pol | 2021 |
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bortezomib; Dexame | 2022 |
Aspirin abrogates impairment of mammary gland differentiation induced by early in life second-hand smoke in mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinogenesis; Cel | 2018 |
Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.
Topics: Adaptive Immunity; Angiotensin II; Animals; Aspirin; Biomarkers; Blood Pressure; Blood Vessels; Card | 2019 |
Prostaglandin E
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Asthma, Aspirin-Induced; Biomarkers | 2019 |
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; BRCA1 Protein; Breast Neo | 2019 |
The PGE2/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection.
Topics: Animals; Aspirin; B-Lymphocytes; Dinoprostone; Disease Susceptibility; Interleukin-10; Leishmania ma | 2015 |
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study.
Topics: Adult; Aspirin; Candidiasis; Carcinoma, Squamous Cell; Case-Control Studies; Disease Susceptibility; | 2012 |
Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma.
Topics: Animals; Antigens, CD19; Aspirin; Asthma; B-Lymphocytes; Case-Control Studies; Cytochrome P-450 Enzy | 2011 |
Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Adhesion; Cyclooxygenase 2; Cyclooxy | 2003 |
Elevated erythrocyte aggregation as a predisposing factor to aspirin resistance.
Topics: Adult; Aspirin; Behcet Syndrome; Coronary Disease; Disease Susceptibility; Drug Resistance; Erythroc | 2003 |
The effect of aspirin, cortisone and other compounds on susceptibility to anaphylactic shock in mice.
Topics: Anaphylaxis; Animals; Aspirin; Cortisone; Disease Susceptibility; Hypersensitivity; Immune System Di | 1957 |
[ETIOLOGY OF THE DUODENAL ULCER].
Topics: Aspirin; Caffeine; Disease Susceptibility; Duodenal Ulcer; Genetics, Medical; Humans; Hyperparathyro | 1964 |
HLA DR typing of aspirin sensitive asthmatics.
Topics: Aspirin; Asthma; Bronchial Spasm; Disease Susceptibility; Drug Hypersensitivity; Female; Genes, MHC | 1984 |
Acetyl salicylic acid alleviates increased susceptibility to thrombosis in pial microvessels of dehydrated mice.
Topics: Animals; Arterioles; Aspirin; Cerebral Veins; Dehydration; Disease Susceptibility; Male; Mice; Mice, | 1994 |
Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Blood Platelets; Disease Susceptibili | 1996 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; A | 1998 |
Cyclooxygenase products are not involved in the protection against myocardial infarction afforded by preconditioning in rabbit. Cyclooxygenase pathway's involvement in preconditioning.
Topics: Analysis of Variance; Animals; Aspirin; Coronary Circulation; Disease Susceptibility; Female; Heart | 1992 |
Platelet activity and stroke severity.
Topics: Aged; Aspirin; Blood Platelets; Brain Ischemia; Calcium; Cardiovascular Agents; Collagen; Disease Su | 1992 |
Asthma and HLA system.
Topics: Alleles; Aspirin; Asthma; Base Sequence; Disease Susceptibility; Genes, Dominant; Genetic Markers; G | 1991 |
Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Disease Susceptibility; Female; Human | 1991 |
Cumulative effects of quinidine and aspirin on bleeding time and platelet alpha 2-adrenoceptors: potential mechanism of bleeding diathesis in patients receiving this combination.
Topics: Aspirin; Bleeding Time; Blood Platelets; Disease Susceptibility; Drug Interactions; Humans; Platelet | 1986 |
The chemical induction of PR (b) proteins and resistance to TMV infection in tobacco.
Topics: Aspirin; Cations; Disease Susceptibility; Nicotiana; Plant Proteins; Plants, Toxic; Thiouracil; Toba | 1986 |
Circadian variation of susceptibility to gastric mucosal injury by acidified aspirin or absolute ethanol in the rat.
Topics: Animals; Aspirin; Circadian Rhythm; Disease Susceptibility; Ethanol; Gastric Mucosa; Male; Rats; Sto | 1986 |
Fatal antral ulcer in conventionally fed W/Wv mutant mice given indomethacin by injection.
Topics: Animals; Aspirin; Dinoprostone; Disease Susceptibility; Fasting; Gastric Mucosa; Indomethacin; Injec | 1985 |
The gastric mucosal response to acetylsalicylic acid in the ferret. An ultrastructural study.
Topics: Animals; Aspirin; Carnivora; Cytoplasm; Disease Susceptibility; Endoplasmic Reticulum; Epithelial Ce | 1973 |